Angiotensin-converting enzyme inhibitors (ACEI) are widely used drugs nowadays in treating patients diagnosed with cardiovascular disorders. We present two consecutive cases of acquired angioedema caused by the administration of enalapril and lisinopril in patients with indication for ACE-inhibitors therapy. Rigorous follow-up of side effects of ACEI is required, due to these possible life-threatening adverse reactions.
INTRODuCTION
Angiotensin converting enzyme inhibitors (ACEI) represent a frequently used medication in daily practice, although little is known about the risk of side effects and mainly about acquired angioedema, a life-threatening complication. Cutaneous adverse reactions labeled on the medication cover a large variety of skin lesions such as urticaria, lichenoid dermatosis, pemphigus, photosensitivity reactions, and angioedema. 1 The first description of angioedema dates from 1876 and belongs to Milton, the terminology of angioneurotic angioedema being used later by Quincke, in 1822.
2 In current daily practice the expression angioedema fully describes the clinical entity that consists of facial edema, including the eyelids, lips, and upper respiratory tract.
Drug-induced angioedema has been reported in association with the administration of various drugs such as nonsteroidal anti-inflammatory drugs, antibiotics, statins, proton pump inhibitors, estrogens, radiocontrast agents, ACEI, beta blockers, calcium channel blockers, and this list can be exhaustive, by recent reports.
3
We present two consecutive cases of acquired angioedema caused by the administration of enalapril and lisinopril in patients with indication for ACEI therapy.
The patients consented to the publication of their data and approval from the institution where they had been admitted was also obtained.
CASE SERIES

Case 1
A 74-year-old male Caucasian patient was seen in the Emergency Unit for diffuse facial and eyelid angioedema 
DISCuSSIONS
The diagnosis of angioedema is mainly clinical and is sug- 
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Treatment of patients diagnosed with ACEI-induced angioedema starts with the recognition of angioedema and of the fact that ACEI could be possible etiologic factors of recurrent facial and upper respiratory edema. 15 The most important recommendation in these cases is to avoid ACEI and revise the medication.
In emergency units angioedema should be treated according to guidelines. 16 The treatment of ACEI-induced angioedema includes icatibant, a bradykinin inhibitor, currently used in patients with hereditary angioedema, or ecallantide, a plasma-derived C1 esterase inhibitor. [17] [18] [19] [20] The presented cases are two examples of ACEI-induced angioedema, both patients having prescribed angiotensin converting enzyme inhibitors for arterial hypertension.
However, the first patient presented the adverse reaction within the first two weeks from initiation of treatment, while the second had a late-onset adverse angioedema. 
